TURNING POINT THERAPEUTICS INC (TPTX)
Currency USD
Company Overview
Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Their internally developed and wholly owned pipeline of next-generation tyrosine kinase inhibitors (TKIs) targets numerous genetic drivers of cancer in both TKI-na've and TKI-pretreated patients. The pervasive challenges of intrinsic and acquired treatment resistance often limit the response rate and durability of existing therapies. One of these challenges is the emergence of solvent front mutations, which are a common cause of acquired resistance to currently approved therapies for ROS1, TRK and ALK kinases. They have developed a macrocycle platform enabling us to design proprietary small, compact TKIs with rigid three-dimensional structures that potentially bind to their targets with greater precision and affinity than other kinase inhibitors.
Contact Details
- Address
- 10628 SCIENCE CENTER DRIVE SUITE 200
- City
- SAN DIEGO
- State
- CA
- Country
- USA
- Zip Code
- 92121
- Phone Number
- 858-926-5251
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...